Arsenite inhibits p53 phosphorylation, DNA binding activity, and p53 target gene p21 expression in mouse epidermal JB6 cells

Faqing Tang, Guangming Liu, Zhiwei He, Wei-Ya Ma, Ann M. Bode, Zigang Dong

Research output: Contribution to journalArticle

23 Scopus citations

Abstract

Epidemiologic investigations demonstrated that arsenite exposure increases the risk of various human cancers, including skin, lung, bladder, and kidney cancers. However, oral administration of arsenite alone has failed to induce tumors in animal models, suggesting that arsenic may act to enhance mutagenicity induced by other carcinogens. Arsenite may function as a co-carcinogen, acting by inhibiting repair of carcinogen-induced DNA damage mediated by p53 and p21, a p53 target gene. To elucidate the interaction between arsenite and p53 tumor suppressor protein, we studied the effect of arsenite on ultraviolet B (UVB)-induced p53 phosphorylation, p53 DNA binding activity, and p53-induced target gene transactivation in the JB6 CI41 mouse epidermal skin cell model. Our results indicated that arsenite suppressed UVB-induced p53 phosphorylation and p53 DNA binding activity. Arsenite also inhibited casein kinase 2 (CK2) activity and decreased p53-regulated p21 protein expression. These data suggest that the direct inhibition of p53 functional activation is one of the mechanisms through which arsenite interferes with p53 function, and thus may be a significant mechanism for the co-carcinogenic effects of arsenite.

Original languageEnglish (US)
Pages (from-to)861-870
Number of pages10
JournalMolecular Carcinogenesis
Volume45
Issue number11
DOIs
StatePublished - Nov 2006

Keywords

  • Arsenite
  • CK2
  • Epidermal mouse JB6 CI41 cells
  • UVB
  • p21
  • p53

Fingerprint Dive into the research topics of 'Arsenite inhibits p53 phosphorylation, DNA binding activity, and p53 target gene p21 expression in mouse epidermal JB6 cells'. Together they form a unique fingerprint.

Cite this